BREATHE

Breathe Life Sciences is an international life sciences and pharmaceutical company focused on manufacturing, supplying, and distributing novel medicines and consumer health products. The business operates as a wholly owned subsidiary of Bioxyne and is active across Australia, the United Kingdom, Europe, Japan, and the United States. Its core activities include GMP manufacturing, import/export, wholesale distribution, and white-label product development, with particular emphasis on medicinal cannabis, MDMA, psilocybin, and cannabinoid-derived health products. Breathe Life Sciences also markets own-brand products such as Dr Watson and serves clinics, pharmacies, brand owners, and other commercial partners. The company appears to be more of a commercial manufacturing and distribution platform than a traditional single-asset clinical-stage biotech.